A I-designed proteins may help spot cancer
MIT and Microsoft researchers developed an AI model to design short peptides that sit on nanoparticles and are cleaved by tumor-associated proteases, producing reporter fragments excreted in urine; the approach could enable an at‑home urine test to detect roughly 30 cancer types and is being advanced with ARPA-H, with potential therapeutic applications for the designed peptides.
Why it mattersARPA-H–backed AI-designed protease-targeting peptides for urine tests could redirect R&D funding toward point-of-care cancer screening.
Entities Mentioned
MITMicrosoftMicrosoft ResearchARPA-H